Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 6
Submit an article Journal homepage
86
Views
0
CrossRef citations to date
0
Altmetric
Commentaries

The challenge of unavailable IGH mutational status in CLL in resource-limited settings

Estella MatutesHaematopathology Unit, Hospital Clinic, Barcelona University, Barcelona, Spain; Correspondence[email protected]
&
Aaron PolliackDepartment of Hematology, Hadassah – Hebrew University Medical Center, Jeruslaem, Israel
Pages 1275-1276 | Received 21 Jan 2020, Accepted 27 Jan 2020, Published online: 24 Feb 2020

References

  • International CLL-IPI working group. An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data. Lancet Oncol. 2016;17(6):779–790.
  • da Cunha-Bang C, Christiansen I, Niemann CU. The CLL-IPI applied in a population-based cohort. Blood. 2016;128(17):2181–2183.
  • Mato A, Nabhan C, Kay NE, et al. Real-world clinical experience in the Connect® chronic lymphocytic leukaemia registry: a prospective cohort study of 1494 patients across 199 US centres. Br J Haematol. 2016;175(5):892–903.
  • Lad D, Tejaswi V, Ñalhotra P, et al. Modified CLL International Prognostic Index (CLL-LIPI) using lymphocyte doubling time (LDT) in place of IGHV mutation status in resource-limited settings predicts time to first treatment and overall survival. Leuk Lymphoma. 2020;61(6):1512–1515.
  • Galton D. Sci Basis Med Ann Rev. 1962:152.
  • Bergsagel DE. The chronic leukemias. A review of disease manifestations and the aims of therapy. Can Med Assoc J. 1967;96(25):1615–1620.
  • Molica S, Alberti A. Prognostic value of the lymphocyte doubling time in chronic lymphocytic leukemia. Cancer. 1987;160(11):2712–2716.
  • Montserrat E, Sanchez-Bisono J, Viñolas N, et al. Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance. Br J Haematol. 1986;62(3):567–575.
  • Pepper C, Majid A, Lin TT, et al. Defining the prognosis of early stage chronic lymphocytic leukaemia patients. Br J Haematol. 2012;156(4):499–507.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.